United Therapeutics pens $216M deal to buy SteadyMed, neutralizing pump-based threat to PAH franchise

///United Therapeutics pens $216M deal to buy SteadyMed, neutralizing pump-based threat to PAH franchise

United Therapeutics pens $216M deal to buy SteadyMed, neutralizing pump-based threat to PAH franchise

SteadyMed’s pump technology. (SteadyMed)

Source: https://www.fiercebiotech.com/medtech/united-therapeutics-pens-216m-deal-to-buy-steadymed-neutralizing-pump-based-threat-to-pah

JOIN THE LINKEDIN GROUP
By | 2018-05-02T09:26:54+00:00 May 2nd, 2018|Blog|Comments Off on United Therapeutics pens $216M deal to buy SteadyMed, neutralizing pump-based threat to PAH franchise

About the Author: